Marijuana retailers in Massachusetts recorded $1.65 billion in sales of adult-use products between Jan. 1, 2024, and Jan. 5, 2025.
That’s according to data from the state’s Cannabis Control Commission, which noted that recreational cannabis sales in December 2024 reached $140.2 million, the third-highest monthly total since Massachusetts legalized an adult-use market in November 2018.
Other top sales months were August 2024 ($147.6 million) and July 2024 ($142.8 million).
During the week ended Jan. 5, 2025, flower represented 40.5% of sales, vapes 19% and pre-rolls 12.6%, followed by edibles and concentrates.
In April, Massachusetts cannabis regulators announced that adult-use sales had surpassed $6 billion since the market launched.
According to the latest figures, recreational cannabis sales in Massachusetts now top $7.2 billion.
Despite the monumental sales figures, Bruce Stebbins, acting chair of the CCC, told regional cable network Spectrum News 1 that the market is still developing.
“This is still a new industry,” he said.
“We’re excited about the numbers, but we realize that our attention and our work doesn’t stop.”
During the same period of Jan. 1, 2024-Jan. 5, 2025, retail sales at medical marijuana treatment centers reached $190.3 million.
It is common for medical marijuana sales figures to fall once states launch adult-use markets.
While medical marijuana products often are higher in potency – and, in many states, such purchases are exempt from sales tax – obtaining an MMJ registration typically involves paying a fee.
Medical Disclaimer:
The information provided in these blog posts is intended for general informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. The use of any information provided in these blog posts is solely at your own risk. The authors and the website do not recommend or endorse any specific products, treatments, or procedures mentioned. Reliance on any information in these blog posts is solely at your own discretion.
